Cargando…
Enhancement of electroporation facilitated immunogene therapy via T-reg depletion
Regulatory T cells (T-regs) can negatively impact tumor antigen-specific immune responses after infiltration into tumor tissue. However, depletion of T-regs can facilitate enhanced anti-tumor responses, thus augmenting the potential for immunotherapies. Here we focus on treating a highly aggressive...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139741/ https://www.ncbi.nlm.nih.gov/pubmed/25034887 http://dx.doi.org/10.1038/cgt.2014.35 |
_version_ | 1782331404383682560 |
---|---|
author | Forde, P F Sadadcharam, M Hall, L J O' Donovan, T R de Kruijf, M Byrne, W L O' Sullivan, G C Soden, D M |
author_facet | Forde, P F Sadadcharam, M Hall, L J O' Donovan, T R de Kruijf, M Byrne, W L O' Sullivan, G C Soden, D M |
author_sort | Forde, P F |
collection | PubMed |
description | Regulatory T cells (T-regs) can negatively impact tumor antigen-specific immune responses after infiltration into tumor tissue. However, depletion of T-regs can facilitate enhanced anti-tumor responses, thus augmenting the potential for immunotherapies. Here we focus on treating a highly aggressive form of cancer using a murine melanoma model with a poor prognosis. We utilize a combination of T-reg depletion and immunotherapy plasmid DNA delivered into the B16F10 melanoma tumor model via electroporation. Plasmids encoding murine granulocyte macrophage colony-stimulating factor and human B71 were transfected with electroporation into the tumor and transient elimination of T-regs was achieved with CD25-depleting antibodies (PC61). The combinational treatment effectively depleted T-regs compared to the untreated tumor and significantly reduced lung metastases. The combination treatment was not effective in increasing the survival, but only effective in suppression of metastases. These results indicate the potential for combining T-reg depletion with immunotherapy-based gene electrotransfer to decrease systemic metastasis and potentially enhance survival. |
format | Online Article Text |
id | pubmed-4139741 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-41397412014-08-22 Enhancement of electroporation facilitated immunogene therapy via T-reg depletion Forde, P F Sadadcharam, M Hall, L J O' Donovan, T R de Kruijf, M Byrne, W L O' Sullivan, G C Soden, D M Cancer Gene Ther Original Article Regulatory T cells (T-regs) can negatively impact tumor antigen-specific immune responses after infiltration into tumor tissue. However, depletion of T-regs can facilitate enhanced anti-tumor responses, thus augmenting the potential for immunotherapies. Here we focus on treating a highly aggressive form of cancer using a murine melanoma model with a poor prognosis. We utilize a combination of T-reg depletion and immunotherapy plasmid DNA delivered into the B16F10 melanoma tumor model via electroporation. Plasmids encoding murine granulocyte macrophage colony-stimulating factor and human B71 were transfected with electroporation into the tumor and transient elimination of T-regs was achieved with CD25-depleting antibodies (PC61). The combinational treatment effectively depleted T-regs compared to the untreated tumor and significantly reduced lung metastases. The combination treatment was not effective in increasing the survival, but only effective in suppression of metastases. These results indicate the potential for combining T-reg depletion with immunotherapy-based gene electrotransfer to decrease systemic metastasis and potentially enhance survival. Nature Publishing Group 2014-08 2014-07-18 /pmc/articles/PMC4139741/ /pubmed/25034887 http://dx.doi.org/10.1038/cgt.2014.35 Text en Copyright © 2014 Nature America, Inc. http://creativecommons.org/licenses/by/3.0/ This work is licensed under a Creative Commons Attribution 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/ |
spellingShingle | Original Article Forde, P F Sadadcharam, M Hall, L J O' Donovan, T R de Kruijf, M Byrne, W L O' Sullivan, G C Soden, D M Enhancement of electroporation facilitated immunogene therapy via T-reg depletion |
title | Enhancement of electroporation facilitated immunogene therapy via T-reg depletion |
title_full | Enhancement of electroporation facilitated immunogene therapy via T-reg depletion |
title_fullStr | Enhancement of electroporation facilitated immunogene therapy via T-reg depletion |
title_full_unstemmed | Enhancement of electroporation facilitated immunogene therapy via T-reg depletion |
title_short | Enhancement of electroporation facilitated immunogene therapy via T-reg depletion |
title_sort | enhancement of electroporation facilitated immunogene therapy via t-reg depletion |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139741/ https://www.ncbi.nlm.nih.gov/pubmed/25034887 http://dx.doi.org/10.1038/cgt.2014.35 |
work_keys_str_mv | AT fordepf enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion AT sadadcharamm enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion AT halllj enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion AT odonovantr enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion AT dekruijfm enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion AT byrnewl enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion AT osullivangc enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion AT sodendm enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion |